Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of PFIZER. For more details, see the PFIZER quarterly results and PFIZER share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.9 |
No. of shares | m | 45.75 |
1 Week | % | 1.2 |
1 Month | % | -2.7 |
1 Year | % | 9.9 |
52 week H/L | Rs | 4,940.0/3,702.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
PFIZER EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 3,840 | 4,930 | 5,875 | 6,165 | 4,662 | |
Low | Rs | 2,080 | 2,798 | 3,833 | 4,163 | 3,407 | |
Sales per share (Unadj.) | Rs | 455.0 | 470.3 | 489.3 | 570.7 | 530.0 | |
Earnings per share (Unadj.) | Rs | 93.8 | 111.3 | 108.8 | 133.9 | 136.4 | |
Diluted earnings per share | Rs | 93.8 | 111.3 | 108.8 | 133.9 | 136.4 | |
Cash flow per share (Unadj.) | Rs | 109.4 | 133.9 | 132.7 | 159.0 | 159.4 | |
Dividends per share (Unadj.) | Rs | 22.50 | 330.00 | 35.00 | 30.00 | 70.00 | |
Adj. dividends per share | Rs | 22.50 | 330.02 | 35.00 | 30.00 | 70.00 | |
Avg Dividend yield | % | 0.8 | 8.5 | 0.7 | 0.6 | 1.7 | |
Book value per share (Unadj.) | Rs | 658.2 | 742.2 | 523.1 | 626.1 | 701.0 | |
Adj. book value per share | Rs | 658.2 | 742.2 | 523.1 | 626.1 | 701.1 | |
Shares outstanding (eoy) | m | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
Price / Sales ratio | x | 6.5 | 8.2 | 9.9 | 9.0 | 7.6 | |
Avg P/E ratio | x | 31.6 | 34.7 | 44.6 | 38.6 | 29.6 | |
P/CF ratio (eoy) | x | 27.1 | 28.9 | 36.6 | 32.5 | 25.3 | |
Price / Book Value ratio | x | 4.5 | 5.2 | 9.3 | 8.2 | 5.8 | |
Dividend payout | % | 24.0 | 296.5 | 32.2 | 22.4 | 51.3 | |
Avg Mkt Cap | Rs m | 135,413 | 176,754 | 222,063 | 236,225 | 184,576 | |
Total wages/salary | Rs m | 3,238 | 3,645 | 3,611 | 4,037 | 3,317 |
PFIZER INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 20,815 | 21,517 | 22,386 | 26,110 | 24,248 | |
Other income | Rs m | 1,674 | 1,840 | 811 | 627 | 1,011 | |
Total revenues | Rs m | 22,489 | 23,357 | 23,197 | 26,736 | 25,258 | |
Gross profit | Rs m | 5,656 | 5,727 | 7,124 | 8,359 | 8,420 | |
Depreciation | Rs m | 714 | 1,032 | 1,094 | 1,150 | 1,055 | |
Interest | Rs m | 17 | 110 | 154 | 107 | 135 | |
Profit before tax | Rs m | 6,599 | 6,425 | 6,687 | 7,729 | 8,240 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,309 | 1,334 | 1,711 | 1,603 | 2,001 | |
Profit after tax | Rs m | 4,291 | 5,091 | 4,976 | 6,126 | 6,239 | |
Gross profit margin | % | 27.2 | 26.6 | 31.8 | 32.0 | 34.7 | |
Effective tax rate | % | 35.0 | 20.8 | 25.6 | 20.7 | 24.3 | |
Net profit margin | % | 20.6 | 23.7 | 22.2 | 23.5 | 25.7 |
PFIZER BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 27,017 | 30,131 | 18,733 | 23,614 | 24,933 | |
Current liabilities | Rs m | 8,917 | 8,734 | 7,743 | 8,529 | 6,574 | |
Net working cap to sales | % | 87.0 | 99.4 | 49.1 | 57.8 | 75.7 | |
Current ratio | x | 3.0 | 3.4 | 2.4 | 2.8 | 3.8 | |
Inventory Days | Days | 59 | 65 | 73 | 82 | 93 | |
Debtors Days | Days | 3 | 3 | 2 | 2 | 2 | |
Net fixed assets | Rs m | 12,246 | 13,565 | 13,440 | 14,571 | 13,780 | |
Share capital | Rs m | 458 | 458 | 458 | 458 | 458 | |
"Free" reserves | Rs m | 29,656 | 33,497 | 23,473 | 28,187 | 31,616 | |
Net worth | Rs m | 30,113 | 33,955 | 23,930 | 28,644 | 32,073 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 39,400 | 44,048 | 32,524 | 38,535 | 39,031 | |
Interest coverage | x | 384.7 | 59.4 | 44.5 | 73.2 | 62.1 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.7 | 0.7 | 0.6 | |
Return on assets | % | 10.9 | 11.8 | 15.8 | 16.2 | 16.3 | |
Return on equity | % | 14.2 | 15.0 | 20.8 | 21.4 | 19.5 | |
Return on capital | % | 22.0 | 19.2 | 28.6 | 27.4 | 26.1 | |
Exports to sales | % | 2.1 | 1.8 | 1.5 | 3.0 | 2.8 | |
Imports to sales | % | 3.8 | 1.9 | 2.3 | 2.5 | 0 | |
Exports (fob) | Rs m | 428 | 398 | 339 | 781 | 688 | |
Imports (cif) | Rs m | 786 | 411 | 510 | 652 | 8 | |
Fx inflow | Rs m | 428 | 398 | 339 | 781 | 688 | |
Fx outflow | Rs m | 786 | 411 | 510 | 652 | 8 | |
Net fx | Rs m | -358 | -14 | -171 | 130 | 679 |
PFIZER CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 978 | 3,232 | 4,273 | 6,671 | 3,557 | |
From Investments | Rs m | 351 | 15,303 | -4,688 | -5,750 | -361 | |
From Financial Activity | Rs m | -1,099 | -1,635 | -15,711 | -1,805 | -3,458 | |
Net Cashflow | Rs m | 231 | 16,900 | -16,126 | -885 | -262 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Pradip Shah | COMP SEC: Prajeet Nair | YEAR OF INC: 1950 | BSE CODE: 500680 | FV (Rs): 10 | DIV YIELD (%): 1.7 |
Read: PFIZER 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare PFIZER With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets continued the momentum as the session progressed and ended the higher.